We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
Cap. Flow
-$307M
Cap. Flow %
-4.25%
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679

Sector Composition

Rank Sector Weight
1 Financials 12.25%
2 Industrials 9.66%
3 Utilities 9.48%
4 Technology 8.06%
5 Healthcare 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCW
1726
DELISTED
Mister Car Wash
MCW
$144K ﹤0.01%
+16,705
New +$157K
SPWR icon
1727
SunPower Inc
SPWR
$60.2M
$144K ﹤0.01%
13,959
-269,878
-95% -$2.75M
SAND
1728
DELISTED
Sandstorm Gold
SAND
$142K ﹤0.01%
+24,455
New +$134K
PDSB icon
1729
PDS Biotechnology
PDSB
$40.3M
$142K ﹤0.01%
+23,031
New +$188K
ORGO icon
1730
Organogenesis Holdings
ORGO
$305M
$141K ﹤0.01%
+66,150
New +$163K
LUNA
1731
DELISTED
Luna Innovations Incorporated
LUNA
$140K ﹤0.01%
+19,488
New +$172K
HAYW icon
1732
Hayward Holdings
HAYW
$3.41B
$140K ﹤0.01%
+11,942
New +$146K
ALKT icon
1733
Alkami Technology
ALKT
$2.02B
$139K ﹤0.01%
+10,994
New +$162K
AQN icon
1734
Algonquin Power & Utilities
AQN
$4.46B
$138K ﹤0.01%
16,435
-15,828
-49% -$119K
CDNA icon
1735
CareDx
CDNA
$2.44B
$138K ﹤0.01%
+15,095
New +$193K
PNT
1736
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$137K ﹤0.01%
+18,883
New +$140K
INZY
1737
DELISTED
Inozyme Pharma
INZY
$137K ﹤0.01%
+23,900
New +$63.2K
PSNY icon
1738
CALL
Polestar Automotive Holding UK
PSNY
$2.12B
$136K ﹤0.01%
1,200
+680
+131% +$103K
FIP icon
1739
FTAI Infrastructure
FIP
$402M
$136K ﹤0.01%
+45,361
New +$138K
HT
1740
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$136K ﹤0.01%
+20,250
New +$164K
APEI icon
1741
American Public Education
APEI
$980M
$136K ﹤0.01%
+25,100
New +$263K
IE icon
1742
Ivanhoe Electric
IE
$1.66B
$136K ﹤0.01%
+11,196
New +$150K
PRQR icon
1743
ProQR Therapeutics
PRQR
$258M
$136K ﹤0.01%
+63,847
New +$195K
WW
1744
DELISTED
WW International
WW
$136K ﹤0.01%
+32,943
New +$144K
AGNC icon
1745
AGNC Investment
AGNC
$12.6B
$135K ﹤0.01%
13,372
+1,451
+12% +$15.8K
HOPE icon
1746
Hope Bancorp
HOPE
$1.83B
$134K ﹤0.01%
+13,630
New +$167K
CGC
1747
PUT
Canopy Growth
CGC
$393M
$133K ﹤0.01%
+7,610
New +$181K
CHS
1748
DELISTED
Chicos FAS, Inc.
CHS
$133K ﹤0.01%
+24,156
New +$129K
ERAS icon
1749
Erasca
ERAS
$6.38B
$132K ﹤0.01%
+43,969
New +$160K
WHWK
1750
Whitehawk Therapeutics
WHWK
$205M
$129K ﹤0.01%
+17,879
New +$191K

Similar funds

Verition Fund Management's Q1 2023 Portfolio in Review

As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.

Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.

  • Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
  • Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
  • Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
  • Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
  • Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
  • Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
  • Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.

Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.